These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 11526368)

  • 21. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators.
    Van Herendael H; Pinter A; Ahmad K; Korley V; Mangat I; Dorian P
    Europace; 2010 May; 12(5):618-25. PubMed ID: 20304841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomised assignment to implantable cardioverter defibrillator or antiarrhythmic drug therapy.
    Cappato R; Boczor S; Kuck KH;
    Eur Heart J; 2004 Apr; 25(8):642-9. PubMed ID: 15084368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical predictors of appropriate implantable-cardioverter defibrillator discharge.
    Catanzaro JN; Makaryus AN; Sison C; Vavasis C; Donaldson D; Beldner S; Boal B; Jadonath R
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S120-4. PubMed ID: 17302686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
    Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S
    Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA; McAnulty J; Zipes DP; Baessler C; Hallstrom AP;
    Am Heart J; 2006 Oct; 152(4):724-30. PubMed ID: 16996848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Klein RC; Raitt MH; Wilkoff BL; Beckman KJ; Coromilas J; Wyse DG; Friedman PL; Martins JB; Epstein AE; Hallstrom AP; Ledingham RB; Belco KM; Greene HL;
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9):940-8. PubMed ID: 12950538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators.
    Steinberg JS; Beckman K; Greene HL; Marinchak R; Klein RC; Greer SG; Ehlert F; Foster P; Menchavez E; Raitt M; Wathen MS; Morris M; Hallstrom A
    J Cardiovasc Electrophysiol; 2001 Sep; 12(9):996-1001. PubMed ID: 11573709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
    Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
    Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
    Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
    Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
    Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.